Insiders ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 04:54:41 16/05/2024 BST			5-day change	1st Jan Change
0.088 ^AUD	+4.76%		+17.95%	-36.55%

04-30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
04-30	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	04-17	MT
Impedimed Names Independent Non-Executive Chair	02-27	MT
ImpediMed CEO, CFO Step Down; Shares Fall 11%	11-20	MT
ImpediMed Limited Announces CEO Changes	11-19	CI
ImpediMed Limited Announces Management Changes	11-19	CI
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03/10/23	CI
Impedimed Limited Announces Board Changes	28/09/23	CI
ImpediMed Appoints Medical Chief; Shares Down 3%	27/09/23	MT
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	26/09/23	CI
ImpediMed Limited Appoints Daniel Sharp as Director	03/07/23	CI
Impedimed Limited Announces the Appointment of Michael Seiden as Independent Non-Executive Directors, Effective 1 July 2023	27/06/23	CI
Impedimed Appoints Managing Director/CEO	29/11/22	MT
ImpediMed Limited Appoints Richard Valencia as Managing Director, Effective 1 December 2022	28/11/22	CI
Impedimed Limited Announces CEO Changes	28/11/22	CI
Impedimed Reorganizes Management Structure	22/11/22	MT
ImpediMed Limited Announces Management Changes	21/11/22	CI
ImpediMed Limited Announces Board Changes	29/08/22	CI
Impedimed Appoints Interim CEO; Shares Fall 7%	26/07/22	MT
ImpediMed Limited Announces Executive Changes	25/07/22	CI
ImpediMed Limited Announces Resignation of Richard Carreon as Managing Director	25/07/22	CI

No results for this search